Posted:
12/16/2025, 9:27:11 AM
Location(s):
Boston, Massachusetts, United States ⋅ Massachusetts, United States
Experience Level(s):
Expert or higher ⋅ Senior
Field(s):
Medical, Clinical & Veterinary
Company Overview
Tango Therapeutics is a biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer.
Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer.
This includes expanding the universe of precision oncology targets into novel areas such as tumor suppressor gene loss and their contribution to the ability of cancer cells to evade immune cell killing.
The Tango labs and offices are located at 201 Brookline Avenue, in the Fenway area of Boston, Massachusetts.
Summary
Tango Therapeutics is seeking a Senior Director of Medical Affairs to support our lead oncology program as it enters its first pivotal study. Reporting to the SVP, Head of Clinical Development, this role is centered on hands-on Medical Affairs execution; overseeing key vendors, managing budgets and timelines, and ensuring high-quality deliverables across medical information, field operations, and evidence-generation partners.
You will lead a global MSL team, driving consistent field engagement, supporting site activation and accrual, and ensuring alignment with clinical development priorities. The role also includes coordinating patient advocacy efforts and maintaining strong cross-functional communication to support late-stage development and prepare for future commercialization.
Your Role
What You Bring
We are an equal opportunity employer and value diversity at our company. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.
LI-Remote
Website: https://www.tangotx.com/
Headquarter Location: Cambridge, Massachusetts, United States
Employee Count: 101-250
Year Founded: 2017
IPO Status: Public
Last Funding Type: Post-IPO Equity
Industries: Biotechnology ⋅ Health Care ⋅ Medical ⋅ Therapeutics